Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets

John Turk, John A. Corbett, Sasanka Ramanadham, Alan Bohrer, Michael L. McDaniel

Research output: Contribution to journalArticle

170 Scopus citations


Streptozotocin (STZ) is selectively toxic to insulin-secreting β-cells of pancreatic islets and induces impairment of islet glucose oxidation and of glucose-induced insulin secretion. Similar effects are induced by Interleukin-1 (IL-1), and the deleterious effects of IL-1 on islets appear to be mediated by nitric oxide (NO). STZ contains a nitroso moiety and may liberate NO by processes analogous to those for the NO-releasing drug nitroprusside. NO is rapidly transformed to nitrite in aqueous solution, and NO activates heme-containing enzymes such as guanylyl cyclase and inhibits iron-sulfur enzymes such as mitochondrial aconitase. Data presented here indicate that incubation of rat islets with STZ at concentrations that impair insulin secretion results in generation of nitrite, stimulation of islet guanylyl cyclase and accumulation of cGMP, and inhibition of islet mitochondrial aconitase activity to a degree similar to that achieved by IL-1. Effects of STZ on β-cells may be mediated by local liberation of NO from STZ within islets.

Original languageEnglish
Pages (from-to)1458-1464
Number of pages7
JournalBiochemical and Biophysical Research Communications
Issue number3
StatePublished - Dec 30 1993

Fingerprint Dive into the research topics of 'Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets'. Together they form a unique fingerprint.

  • Cite this